The biosynthesis of the azabicyclic ring system of the azinomycin family of antitumor agents represents the "crown jewel" of the pathway and is a complex process involving at least 14 enzymatic steps. This study reports on the first biosynthetic step, the inroads, in the construction of the novel aziridino [1,2-a]pyrrolidine, azabicyclic core, allowing us to support a new mechanism for azabicycle formation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.biochem.6b01108 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!